Commonwealth Equity Services’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $149K | Buy |
72,120
+4,819
| +7% | +$9.96K | ﹤0.01% | 3993 |
|
2025
Q1 | $148K | Sell |
67,301
-925
| -1% | -$2.03K | ﹤0.01% | 3920 |
|
2024
Q4 | $104K | Buy |
68,226
+4,550
| +7% | +$6.94K | ﹤0.01% | 3898 |
|
2024
Q3 | $127K | Buy |
63,676
+6,925
| +12% | +$13.8K | ﹤0.01% | 3826 |
|
2024
Q2 | $199K | Sell |
56,751
-281,775
| -83% | -$988K | ﹤0.01% | 3639 |
|
2024
Q1 | $938K | Buy |
338,526
+10,122
| +3% | +$28K | ﹤0.01% | 2303 |
|
2023
Q4 | $558K | Buy |
328,404
+13,578
| +4% | +$23.1K | ﹤0.01% | 2611 |
|
2023
Q3 | $324K | Buy |
314,826
+16,467
| +6% | +$16.9K | ﹤0.01% | 2958 |
|
2023
Q2 | $346K | Buy |
298,359
+278,497
| +1,402% | +$323K | ﹤0.01% | 2928 |
|
2023
Q1 | $29 | Sell |
19,862
-750
| -4% | -$1 | ﹤0.01% | 3633 |
|
2022
Q4 | $51K | Sell |
20,612
-525
| -2% | -$1.3K | ﹤0.01% | 3515 |
|
2022
Q3 | $89K | Buy |
21,137
+4,615
| +28% | +$19.4K | ﹤0.01% | 3392 |
|
2022
Q2 | $46K | Buy |
16,522
+5,000
| +43% | +$13.9K | ﹤0.01% | 3498 |
|
2022
Q1 | $65K | Sell |
11,522
-80
| -0.7% | -$451 | ﹤0.01% | 3552 |
|
2021
Q4 | $105K | Sell |
11,602
-19,458
| -63% | -$176K | ﹤0.01% | 3443 |
|
2021
Q3 | $332K | Sell |
31,060
-371
| -1% | -$3.97K | ﹤0.01% | 2816 |
|
2021
Q2 | $487K | Buy |
31,431
+516
| +2% | +$8K | ﹤0.01% | 2489 |
|
2021
Q1 | $501K | Buy |
30,915
+3,706
| +14% | +$60.1K | ﹤0.01% | 2331 |
|
2020
Q4 | $575K | Sell |
27,209
-819
| -3% | -$17.3K | ﹤0.01% | 2054 |
|
2020
Q3 | $415K | Sell |
28,028
-2,067
| -7% | -$30.6K | ﹤0.01% | 2097 |
|
2020
Q2 | $442K | Buy |
30,095
+13,506
| +81% | +$198K | ﹤0.01% | 1972 |
|
2020
Q1 | $194K | Buy |
16,589
+4,339
| +35% | +$50.7K | ﹤0.01% | 2409 |
|
2019
Q4 | $287K | Buy |
12,250
+200
| +2% | +$4.69K | ﹤0.01% | 2356 |
|
2019
Q3 | $222K | Buy |
+12,050
| New | +$222K | ﹤0.01% | 2478 |
|